Viyash Scientific share news and announcements
NSE: VIYASHBSE: 512529Pharmaceuticals & BiotechnologySmall Cap
Formerly Sequent Scientific
Last close ₹204.18down ₹3.81 (1.83%)BSE ₹203.45
Share price at the NSE close on 23 Oct 2026. Previous close ₹207.99.
52-week range of traded prices to 23 Oct 2026
₹178.13Low, 23 Mar 2026₹298.00High, 6 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9,017 Cr598th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 44,68,18350.3% delivered
Viyash Scientific share news and announcements
593 announcements, routine notices left out, newest first. Page 12 of 12.
Jun 2017
May 2017
23 May · Disclosure
23 May · Board meeting
2 May · News Verification
Exchange has sought clarification from Sequent Scientific Limited with respect to recent news item captioned "Sequent Scientific Receives EIR for API Plant At Vizag.". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Apr 2017
Mar 2017
Feb 2017
22 Feb · Meeting
Nov 2016
Oct 2016
Sep 2016
26 Sep · Regulation 44(3) of SEBI (LODR), Reg., 2015
21 Sep · Analysts
Aug 2016
Jul 2016
Jun 2016
16 Jun · News Verification
Exchange has sought clarification from Sequent Scientific Limited with respect to recent news item captioned "Food and Drug Administration (FDA) orders suspension of Mahad unit." In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
May 2016
Apr 2016
Mar 2016